**Chapter 2**

*Drug Repurposing - Hypothesis, Molecular Aspects and Therapeutic Applications*

[43] GNS HS, GR S, Murahari M, Krishnamurthy M. An update on drug repurposing: Re-written saga of the drug's fate. Biomedicine & Pharmacotherapy. 2019;**110**:700-716

repurposing, repositioning and rescue. Part II: Business review. Drug Discovery

[35] Naylor S, Schonfeld JM. Therapeutic

drug repurposing, repositioning and rescue: Part I—Overview. Drug Discovery World. 2014;**16**:49-62

[36] Jin G, Wong STC. Toward better drug repositioning: Prioritizing and integrating existing methods into efficient pipelines. Drug Discovery

[38] Jourdan JP, Bureau R, Rochais C, Dallemagne P. Drug repositioning: A brief overview. The Journal of Pharmacy and Pharmacology. 2020. DOI: 10.1111/

[39] Li YY, Jones SJ, Smith M. The importance of drug repositioning in the era of genomic medicine drug repositioning for personalized medicine. Review. Genome Medicine.

[40] Hernandez JJ, Pryszlak M, Smith L, et al. Giving drugs a second chance: Overcoming regulatory and financial hurdles in repurposing approved drugs as cancer therapeutics. Frontiers in

World. 2015;**16**:57-72

Today. 2014;**19**:637-644

2015;**16**:62-69

jphp.13273

2012;**4**:27

Oncology. 2017;**7**:1-8

[41] Boguski MS, Mandl KD, Sukhatme VP. Repurposing with a difference. Science. 2019;**324**:1394-1395

[42] Simsek M, Meijer B, van

Bodegraven AA, et al. Finding hidden treasures in old drugs: The challenges and importance of licensing generics. Drug Discovery Today. 2018;**23**:17-21

[37] Naylor S, Kauppi DM, Schonfeld JM. Therapeutic drug repurposing, repositioning and rescue. Part III: Market exclusivity using intellectual property and regulatory pathways. Drug Discovery World.

**22**
